Sports in Hypertension of the Elderly
The Impact of Pulse Pressure on Cardiovascular Effects of Exercise Training in Hypertension of the Elderly
1 other identifier
interventional
54
1 country
1
Brief Summary
The present work examines the impact of pulse pressure as a footprint of vascular ageing on cardiovascular benefits of endurance training in elderly hypertensives. METHODS AND RESULTS: 54 patients ≥ 60 years with antihypertensive treatment and diastolic 24h-ambulatory blood pressure (ABP) ≤ 90 mmHg are randomly assigned to sedentary activity or a heart-rate controlled 12 week exercise program, consisting of walking on a treadmill at target lactate concentrations of 2.5 ± 0.5 mmol/l. 24h-ambulatory blood pressure, physical performance, arterial elasticity, endothelium-derived vasodilation, quality of life, and weight are assessed at baseline and follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hypertension
Started Feb 2005
Shorter than P25 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2005
CompletedFirst Submitted
Initial submission to the registry
April 14, 2006
CompletedFirst Posted
Study publicly available on registry
April 18, 2006
CompletedApril 18, 2006
March 1, 2005
April 14, 2006
April 14, 2006
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Decrease of 24h-ambulatory systolic blood pressure
Secondary Outcomes (4)
change of diastolic blood pressure
change of pulse pressure
change of arterial compliance
change of endothelium-derived vasodilation
Interventions
Eligibility Criteria
You may qualify if:
- ≥ 60 years antihypertensive treatment diastolic 24h-ambulatory blood pressure (ABP) ≤ 90 mmHg
You may not qualify if:
- regular engagement in physical exercise training in the past 12 weeks symptomatic peripheral arterial occlusive disease aortic insufficiency or stenosis \> stage I hypertrophic obstructive cardiomyopathy (HOCM) congestive heart failure (\> NYHA II) uncontrolled cardiac arrhythmia with haemodynamic relevance systolic office BP ≥ 180 mmHg signs of acute ischemia in exercise ECG change of antihypertensive medication in the past 6 weeks or during follow-up period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Charité, Campus Benjamin Franklin
Berlin, 12200, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Timm H Westhoff, MD
Charité, Campus Benjamin Franklin, Medizinische Klinik IV, Berlin, Germany
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 14, 2006
First Posted
April 18, 2006
Study Start
February 1, 2005
Study Completion
October 1, 2005
Last Updated
April 18, 2006
Record last verified: 2005-03